Fortress Biotech is a biopharmaceutical company that acquires and advances promising drug candidates and products to generate shareholder value through multiple revenue streams including product sales, royalties, milestone payments, and equity appreciation. The company works with academic institutions and pharmaceutical partners to identify assets, then leverages its scientific and regulatory expertise to help subsidiaries and partner companies—many of which are publicly traded—advance therapies through development and commercialization. Fortress generates revenue from direct product sales through subsidiaries like Journey Medical (dermatology), royalties and milestone payments from partner companies pursuing drug development across oncology, immunology, genetic diseases, and other areas, and from strategic exits and equity ownership in partner companies.